SUBSCRIBE
SUBSCRIBE
News   Deals

GlaxoSmithKline Nears Deal to Buy Chinese Drugmaker Nanjing MeiRui Pharma

December 2, 2010 | 
1 min read
LONDON, Dec 1 (Reuters) - GlaxoSmithKline (GSK.L) plans to acquire Chinese drugmaker Nanjing MeiRui Pharma in its latest drive into emerging markets, sources familiar with the situation said on Wednesday.
Mergers & acquisitions Europe
GlaxoSmithKline
MORE ON THIS TOPIC
Pleasanton, CA, USA - Feb 21, 2024: Exterior view of the headquarters of Roche Molecular Diagnostics (RMD) in Pleasanton, California. F. Hoffmann-La Roche AG is a Swiss pharmaceutical company.
Lung cancer
Roche Spends $570M on Another ADC Agreement With China’s MediLink
January 9, 2026
 · 
1 min read
 · 
Tristan Manalac
Trendy halftone business concept collage. Idea concept, business concept, financial planning,financial profit, favorable conditions, favorable conditions. Trendy modern retro illustration in bright trendy colors. Vector illustration
Mergers & acquisitions
Revolution Soars Amid Swirling Buyout Rumors With Merck, AbbVie
January 9, 2026
 · 
1 min read
 · 
Tristan Manalac
Insights
From Nuclear Winter to Renewal: Biotech Investing for 2026
January 8, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Illustration of two hands shaking while another hand gently grips a wrist
Collaboration
Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact
January 8, 2026
 · 
2 min read
 · 
Tristan Manalac